These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 36291628)

  • 1. Systemic Biomarkers and Unique Pathways in Different Phenotypes of Heart Failure with Preserved Ejection Fraction.
    Chen H; Tesic M; Nikolic VN; Pavlovic M; Vucic RM; Spasic A; Jovanovic H; Jovanovic I; Town SEL; Padula MP; McClements L
    Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomics to improve phenotyping in obese patients with heart failure with preserved ejection fraction.
    Kresoja KP; Rommel KP; Wachter R; Henger S; Besler C; Klöting N; Schnelle M; Hoffmann A; Büttner P; Ceglarek U; Thiele H; Scholz M; Edelmann F; Blüher M; Lurz P
    Eur J Heart Fail; 2021 Oct; 23(10):1633-1644. PubMed ID: 34231954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic Evaluation of the Comorbidity-Inflammation Paradigm in Heart Failure With Preserved Ejection Fraction: Results From the PROMIS-HFpEF Study.
    Sanders-van Wijk S; Tromp J; Beussink-Nelson L; Hage C; Svedlund S; Saraste A; Swat SA; Sanchez C; Njoroge J; Tan RS; Fermer ML; Gan LM; Lund LH; Lam CSP; Shah SJ
    Circulation; 2020 Nov; 142(21):2029-2044. PubMed ID: 33034202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma proteomic analysis of association between atrial fibrillation, coronary microvascular disease and heart failure.
    Dixit G; Blair J; Ozcan C
    Am J Cardiovasc Dis; 2022; 12(2):81-91. PubMed ID: 35600285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FK506-Binding Protein like (FKBPL) Has an Important Role in Heart Failure with Preserved Ejection Fraction Pathogenesis with Potential Diagnostic Utility.
    Chhor M; Chen H; Jerotić D; Tešić M; Nikolić VN; Pavlović M; Vučić RM; Rayner B; Watson CJ; Ledwidge M; McDonald K; Robson T; McGrath KC; McClements L
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic analysis of epicardial adipose tissue from heart disease patients with concomitant heart failure with preserved ejection fraction.
    He S; Zhu H; Zhang J; Wu X; Zhao L; Yang X
    Int J Cardiol; 2022 Sep; 362():118-125. PubMed ID: 35662556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced clinical phenotyping by mechanistic bioprofiling in heart failure with preserved ejection fraction: insights from the MEDIA-DHF study (The Metabolic Road to Diastolic Heart Failure).
    Stienen S; Ferreira JP; Kobayashi M; Preud'homme G; Dobre D; Machu JL; Duarte K; Bresso E; Devignes MD; López N; Girerd N; Aakhus S; Ambrosio G; Brunner-La Rocca HP; Fontes-Carvalho R; Fraser AG; van Heerebeek L; Heymans S; de Keulenaer G; Marino P; McDonald K; Mebazaa A; Papp Z; Raddino R; Tschöpe C; Paulus WJ; Zannad F; Rossignol P
    Biomarkers; 2020 Mar; 25(2):201-211. PubMed ID: 32063068
    [No Abstract]   [Full Text] [Related]  

  • 8. Association Between Heart Failure With Preserved Left Ventricular Ejection Fraction and Impaired Left Atrial Phasic Function in Hypertrophic Cardiomyopathy: Evaluation by Cardiac MRI Feature Tracking.
    Shi R; Shi K; Huang S; Li X; Xia CC; Li Y; He S; Li ZL; He Y; Guo YK; Yang ZG
    J Magn Reson Imaging; 2022 Jul; 56(1):248-259. PubMed ID: 34799953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of heart failure with preserved ejection fraction helps risk stratification for hypertrophic cardiomyopathy.
    Liu J; Wang D; Ruan J; Wu G; Xu L; Jiang W; Wang J; Sun X; Kang L; Song L
    BMC Med; 2022 Jan; 20(1):21. PubMed ID: 35078475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin Growth Factor Phenotypes in Heart Failure With Preserved Ejection Fraction, an INSPIRE Registry and CATHGEN Study.
    Haddad F; Ataam JA; Amsallem M; Cauwenberghs N; Kuznetsova T; Rosenberg-Hasson Y; Zamanian RT; Karakikes I; Horne BD; Muhlestein JB; Kwee L; Shah S; Maecker H; Knight S; Knowlton K
    J Card Fail; 2022 Jun; 28(6):935-946. PubMed ID: 34979242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying Pathophysiological Mechanisms in Heart Failure With Reduced Versus Preserved Ejection Fraction.
    Tromp J; Westenbrink BD; Ouwerkerk W; van Veldhuisen DJ; Samani NJ; Ponikowski P; Metra M; Anker SD; Cleland JG; Dickstein K; Filippatos G; van der Harst P; Lang CC; Ng LL; Zannad F; Zwinderman AH; Hillege HL; van der Meer P; Voors AA
    J Am Coll Cardiol; 2018 Sep; 72(10):1081-1090. PubMed ID: 30165978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic Signatures of Heart Failure in Relation to Left Ventricular Ejection Fraction.
    Adamo L; Yu J; Rocha-Resende C; Javaheri A; Head RD; Mann DL
    J Am Coll Cardiol; 2020 Oct; 76(17):1982-1994. PubMed ID: 33092734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obese-Inflammatory Phenotypes in Heart Failure With Preserved Ejection Fraction.
    Sabbah MS; Fayyaz AU; de Denus S; Felker GM; Borlaug BA; Dasari S; Carter RE; Redfield MM
    Circ Heart Fail; 2020 Aug; 13(8):e006414. PubMed ID: 32809874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarker Profiles of Acute Heart Failure Patients With a Mid-Range Ejection Fraction.
    Tromp J; Khan MAF; Mentz RJ; O'Connor CM; Metra M; Dittrich HC; Ponikowski P; Teerlink JR; Cotter G; Davison B; Cleland JGF; Givertz MM; Bloomfield DM; Van Veldhuisen DJ; Hillege HL; Voors AA; van der Meer P
    JACC Heart Fail; 2017 Jul; 5(7):507-517. PubMed ID: 28624483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
    Paulus WJ; Tschöpe C
    J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloperoxidase Inhibition Reverses Biomarker Profiles Associated With Clinical Outcomes in HFpEF.
    Michaëlsson E; Lund LH; Hage C; Shah SJ; Voors AA; Saraste A; Redfors B; Grove EL; Barasa A; Richards AM; Svedlund S; Lagerström-Fermér M; Gabrielsen A; Garkaviy P; Gan LM; Lam CSP
    JACC Heart Fail; 2023 Jul; 11(7):775-787. PubMed ID: 37140510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated proteomic and metabolomic profiling reveals novel insights on the inflammation and immune response in HFpEF.
    Abudurexiti M; Abuduhalike R; Naman T; Wupuer N; Duan D; Keranmu M; Mahemuti A
    BMC Genomics; 2024 Jul; 25(1):676. PubMed ID: 38977985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiplexed measurement of candidate blood protein biomarkers of heart failure.
    Tonry C; McDonald K; Ledwidge M; Hernandez B; Glezeva N; Rooney C; Morrissey B; Pennington SR; Baugh JA; Watson CJ
    ESC Heart Fail; 2021 Jun; 8(3):2248-2258. PubMed ID: 33779078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of biomarkers in cardiac structure phenotyping in heart failure with preserved ejection fraction: critical appraisal and practical use.
    D'Elia E; Vaduganathan M; Gori M; Gavazzi A; Butler J; Senni M
    Eur J Heart Fail; 2015 Dec; 17(12):1231-9. PubMed ID: 26493383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pro-Inflammatory Biomarkers in Stable Versus Acutely Decompensated Heart Failure With Preserved Ejection Fraction.
    Abernethy A; Raza S; Sun JL; Anstrom KJ; Tracy R; Steiner J; VanBuren P; LeWinter MM
    J Am Heart Assoc; 2018 Apr; 7(8):. PubMed ID: 29650706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.